Roche unveils intelligent automation management solution at 2013 Clinical Lab Expo

HOUSTON -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced plans today at the AACC 2013 Clinical Lab Expo for the U.S. introduction of the cobas 8100 automated workflow series, an advanced system designed to automate many routine tasks to help diagnostic laboratories increase efficiency, reduce expenses and maximize patient safety. "This total lab automation solution [...]

AD HOC Announcement According to §15 WpHG: QIAGEN to conduct new $100 million share repurchase program

Venlo, The Netherlands, - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that its Managing Board, upon authorization of the Supervisory Board, has passed a resolution to exercise the authorization granted by the General Meeting of Shareholders on June 26, 2013, and to purchase shares in the Company up to a total of [...]

Morpho Detection Appoints Karen Bomba President and CEO

Newark, Calif. - Morpho (Safran), through its subsidiary Morpho Detection, Inc., today announced the appointment of Karen Bomba to President and CEO, effective immediately. Bomba brings more than a decade of executive experience leading Safran companies to the role. Most recently, Bomba served as Chairman and CEO of Labinal, Safran's electrical wiring systems company. Bomba [...]

Bina Accelerates Growth with Fully Subscribed $8M Series B Round, Adds to Executive Team

Redwood City, CA - Bina Technologies, the genomic big data science platform accelerating personalized medicine, today announced that they have added to their Series B financing round with $1.75M in additional funding, bringing their total Series B round to $8M. The additional funding was led by Mohsen Moazami at Columbus Nova Technology Partners (CNTP) and [...]

BioFire Initiates Clinical Study for the FilmArray® Gastrointestinal Panel

SALT LAKE CITY -- BioFire Diagnostics, Inc., recently announced that it has commenced clinical and analytical studies to evaluate the company’s FilmArray Gastrointestinal (GI) Panel, with plans to seek both CE IVD marking and FDA clearance. The comprehensive 23-target panel tests for common bacteria, viruses and protozoa that cause infectious diarrhea. The test is performed [...]

Quanterix to Present Multiple Sessions at AACC Annual Meeting and Clinical Lab Expo

LEXINGTON, Mass. -- Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that they will be attending the AACC Annual Meeting and Clinical Lab Expo on July 28 – August 1, 2013 in Houston, Texas. Quanterix will be presenting research based on its [...]

NanoString Technologies Introduces nCounter Elements™ Reagents to Support Needs of Translational Research and Clinical Laboratory Testing

SEATTLE and HOUSTON – NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an Early Access Program for nCounter Elements™, a line of General Purpose Reagents (GPRs) developed specifically to meet the needs of translational research and clinical laboratories. nCounter Elements GPRs enable researchers [...]

R&D 100 Award Goes to Waters ACQUITY UPC2 System

MILFORD, Mass. -- Waters Corporation (NYSE: WAT) today announced that R&D Magazine recognized the Waters® ACQUITY UPC2™ System as one of "the 100 most technologically significant products introduced into the marketplace over the past year." The ACQUITY UPC2 System is the first in a new class of separations tools based on the technology of UltraPerformance [...]

BIT Group Partners with BioNano Genomics to Produce Revolutionary Genomics Platform

San Diego, CA -- BIT Group announces the successful partnering with BioNano Genomics of San Diego, CA to produce the Award Winning Irys instrument – part of the Irys System, a revolutionary new genome mapping platform system which allows the study of DNA and the unique aspects of genomes that cannot currently be detected by [...]

Oxford Genetics secures funding for DNA cloning system

Venture capital fund manager Mercia Fund Management (MFM) has announced £150,000 of funding in Oxford Genetics Ltd. The new biotechnology company is behind SnapFast™ - a system that simplifies the purchase of synthetic DNA molecules (plasmids). CEO of Oxford Genetics, Dr Ryan Cawood, invented the SnapFast™ system and likens it to “Lego for DNA”. Historically, [...]

Access IBO on Knowledge Center